X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2587) 2587
Publication (154) 154
Book Review (65) 65
Newsletter (55) 55
Magazine Article (29) 29
Book Chapter (17) 17
Newspaper Article (15) 15
Trade Publication Article (11) 11
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1673) 1673
index medicus (1585) 1585
dabigatran (1518) 1518
dabigatran etexilate (1511) 1511
warfarin (992) 992
anticoagulants (911) 911
rivaroxaban (879) 879
atrial fibrillation (767) 767
anticoagulants - therapeutic use (679) 679
venous thromboembolism (635) 635
male (587) 587
administration, oral (564) 564
prevention (530) 530
female (528) 528
stroke (506) 506
apixaban (504) 504
anticoagulants - adverse effects (494) 494
anticoagulants - administration & dosage (485) 485
aged (481) 481
atrial fibrillation - drug therapy (470) 470
hematology (470) 470
atrial-fibrillation (464) 464
direct thrombin inhibitor (462) 462
beta-alanine - analogs & derivatives (454) 454
pharmacology & pharmacy (426) 426
peripheral vascular disease (418) 418
stroke - prevention & control (398) 398
benzimidazoles - therapeutic use (392) 392
hemorrhage - chemically induced (380) 380
risk factors (364) 364
thromboembolism (353) 353
cardiac & cardiovascular systems (348) 348
benzimidazoles - adverse effects (341) 341
thrombin (338) 338
middle aged (326) 326
drug therapy (313) 313
atrial fibrillation - complications (311) 311
etexilate (310) 310
treatment outcome (309) 309
benzimidazoles - administration & dosage (300) 300
pharmacokinetics (288) 288
double-blind (283) 283
enoxaparin (282) 282
dosage and administration (275) 275
medicine, general & internal (272) 272
anticoagulation (267) 267
stroke prevention (259) 259
aged, 80 and over (246) 246
abridged index medicus (243) 243
antithrombins - adverse effects (239) 239
care and treatment (239) 239
blood coagulation - drug effects (236) 236
warfarin - therapeutic use (232) 232
oral anticoagulants (230) 230
venous thromboembolism - prevention & control (228) 228
pyridines - therapeutic use (227) 227
antithrombins - therapeutic use (223) 223
research (211) 211
stroke - etiology (209) 209
pharmacodynamics (208) 208
thrombosis (208) 208
beta-alanine - adverse effects (205) 205
management (205) 205
safety (204) 204
beta-alanine - therapeutic use (201) 201
deep-vein thrombosis (201) 201
factor-xa inhibitor (201) 201
surgery (196) 196
therapy (196) 196
animals (194) 194
analysis (193) 193
factor xa inhibitors (193) 193
factor xa inhibitor (191) 191
medicine & public health (189) 189
thromboprophylaxis (188) 188
bleeding (186) 186
hemorrhage (185) 185
anticoagulants - pharmacology (181) 181
antithrombins - administration & dosage (179) 179
cardiac arrhythmia (174) 174
health aspects (170) 170
complications and side effects (166) 166
risk (166) 166
beta-alanine - administration & dosage (164) 164
molecular-weight heparin (162) 162
edoxaban (159) 159
pyridines - administration & dosage (157) 157
thrombin - antagonists & inhibitors (157) 157
adult (156) 156
warfarin - adverse effects (156) 156
thromboembolism - prevention & control (151) 151
antithrombotic therapy (150) 150
total hip-replacement (150) 150
usage (150) 150
dabigatran - therapeutic use (147) 147
pyridines - adverse effects (147) 147
vitamin k - antagonists & inhibitors (147) 147
prothrombin complex concentrate (146) 146
coagulation assays (143) 143
cardiology (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2481) 2481
German (51) 51
French (50) 50
Spanish (48) 48
Russian (29) 29
Japanese (11) 11
Czech (10) 10
Italian (5) 5
Portuguese (4) 4
Chinese (2) 2
Danish (2) 2
Hungarian (2) 2
Polish (2) 2
Arabic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 12, pp. 1699 - 1709
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
Dabigatran etexilate has been investigated in three phase III trials for the prevention of venous thromboembolism (VTE). Health technology assessment agencies... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | ENOXAPARIN | meta-analysis | RANDOMIZED-TRIAL | REPLACEMENT | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | THROMBOSIS PROPHYLAXIS | US HOSPITALS | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY | UNFRACTIONATED HEPARIN | REGISTRY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2010, Volume 103, Issue 6, pp. 1116 - 1127
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2013, Volume 75, Issue 4, pp. 1053 - 1062
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 6, pp. 931 - 937.e1
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2012, Volume 107, Issue 5, pp. 985 - 997
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2016, Volume 116, Issue 3, pp. 461 - 471
Venous thromboembolism (VTE) incidence is increasing among children owing to many factors, including improved diagnosis of VIE. There is a need for alternative... 
Direct thrombin inhibitors | Anticoagulants | Dabigatran | Venous thromboembolism | Adolescent | POPULATION | RE-LY TRIAL | THROMBOSIS | MATURATION | CHILDHOOD | ATRIAL-FIBRILLATION | CHILDREN | WARFARIN | venous thromboembolism | PEDIATRIC-PATIENTS | anticoagulants | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | direct thrombin inhibitors
Journal Article
Journal Article
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2007, Volume 5, Issue 11, pp. 2178 - 2185
Journal Article
Thrombosis Research, ISSN 0049-3848, 2016, Volume 144, pp. 1 - 5
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2011, Volume 9, Issue 11, pp. 2168 - 2175
Journal Article